Latest Lupin stock price

Lupin P/E Ratio

LUPIN • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
22.61
Moderate Valuation
High - Growth expectations or overvalued

Current Valuation Metrics

P/E Ratio 22.61
Current Price ₹2190.90
EPS (TTM) ₹71.95
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 29.28
Historical Range 18.62 - 48.06
Percentile 40.0%

Sector Context

Sector Average 57.72
Sector Median 36.22
Sector Rank #11 of 88
Sector Percentile 12.5%

Earnings Breakdown (TTM)

TTM EPS ₹94.69
Sept 2025 ₹32.36
Mar 2025 ₹16.93

Key P/E Ratio Insights for Lupin

  • Current PE is 22.8% below historical average
  • Trading at discount to sector average PE of 57.72

View the LUPIN equity price for detailed stock performance.

P/E Ratio Historical Trend for Lupin

Historical P/E ratio trend based on annual earnings data. Lower P/E ratios may indicate undervaluation, while higher ratios suggest growth expectations.

Historical P/E Ratio Data

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2024 20.87 62.92 ₹1312.85 NSE Moderate
2023 18.62 39.36 ₹732.85 NSE Moderate
2020 30.44 25.33 ₹771.15 NSE High
2017 48.06 31.33 ₹1505.75 NSE High
2016 28.42 64.93 ₹1845.25 NSE High

Sector P/E Ratio Comparison

Comparing Lupin with other companies in Healthcare sector
Sector Average
57.72
Sector Median
36.22
Lowest P/E
9.01
Highest P/E
515.32
Companies
88
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Fermenta Biotech FERMENTA 9.01 ₹1,010 Low
Natco Pharma NATCOPHARM 10.8 ₹17,006 Low
Mohini Health & Hygiene MHHL 11.84 ₹69 Low
Lincoln Pharmaceuticals LINCOLN 12.02 ₹974 Low
QMS Medical Allied Servi… QMSMEDI 12.82 ₹177 Low
Take Solutions TAKE 13.15 ₹638 Low
Venus Remedies VENUSREM 14.27 ₹995 Low
Royal Sense ROYAL 14.5 ₹96 Low
Bliss GVS Pharma BLISSGVS 16.62 ₹1,973 Moderate
RPG Life Sciences RPGLIFE 17.94 ₹3,861 Moderate